HIF1A facilitates cancer development through the promotion of glycolysis via activation of LDHA, a key glycolysis-related enzyme [19, 20, 34, 35], and the content of LDHA was markedly reduced by M4N+TMZ combination treatment (Fig 3A) [47]. Here, HIF1A is linked to cancer.